Post on 14-Jan-2016
NIGERIA Roadmap to Achieve 31.12.2010 RBM
TargetsSeptember 2009 – December 2010
Country Summary
Intervention Need to 2010 Already covered
Funded and expected to be distributed before end 2010
Gap
LLINs 62.9m LLINs: (22.3m from Sept 2009; 40.5m in 2010 @2LLINs /HH with 5pers/HH +wastage)
4.4m 49.378m 9.2m
ACTs 129,194,824 doses: Sept 2009: 28,175,491;
2010: 101,019,333 (80% coverage)
8.3m 94,267,437 34,927,387
IRS 2,540,843 HHs:2009: 280,000; 2010: 2,260,843
840,000 280,000 (2009)
560,000 (2010)
4.24m
RDTs 59, 202,251 tests: 2009: 29,135,153 tests (30% coverage)
2010: 30,067,098tests
0 34,353,875m 28,848,376
IPTp 18.3m dosesSept-Dec 2009: 2,340,830
2010: 16m
18.3m 0
Quinine
Population at risk: (158.9m in 2010)
Country Summary -2.
Intervention Need to 2010 Already covered
Funded and expected to be distributed before end 2010
Gap
M&E $20.4m
(About 10% of Total budget)
WBBP = 15.4m
GF-R8 = 2.4m
WHO = $354,000
2.2m
BCC/IEC $15,768,9782009: 7,940,265; 2010: 7,828,713
1m WBBP: $9m
GF R8: $4.8m
WHO: $350,000
WBBP: $2m (NIFAA)
Human Resources (Capacity Bldg)
10.5m in trainings and TAs (Excluding salaries)
WB = 3.0m
GF R8 = 4.1m
Govt = Salaries of health workers and prog managers at all levels
RBM = TAs
Others:
Service Delivery
Population at risk: (158.9m)
LLIN resources available to achieve the 2010 targets
FUNDS AVAILABLE (US $)
SOURCE COMMENT
Mechanism and when
Available Total Need Gap
140,000 LLINs8,300,00 LLINs3,966,786 LLINs1,949,763 LLINs590,000 LLINs2,782,749 LLINs1,259,048 LLINs3,390,609 LLINs629,533 LLINs
FGN/MDGWB 1WB 2DFIDUSAIDUNITAID / UNICEF GF R4 GF R8USAID
Campaign 2009Campaign 2009Campaign 2009Campaign 2009Campaign 2009Campaign 2009Campaign 2009Campaign 2009Mop-up 2009
22,378,956
629,533
22,378,956
629,533
0
0
3,717,251 LLINs17,807,958 LLINs
UNITAID/UNICEFGF R8
Campaign May-Jun 2010 Campaign May-Jun 2010
21,525,209 21,525,209 0
9,177,755 LLINs GF R8 Campaign Oct-Nov 2010
9,177,755 18,444,832 9,177,755
53,800,775 LLINs TOTAL TOTAL 53,800,775 (4.4m was distr. in Jun-Aug. 09)
62,978,530 9,177,755
LLIN Ordering & Distribution to end 2010
Quantities 62.8m
Procurement dates VPP July 14, 2009[WB, UNITAID/UNICEF]
Expected delivery In country. Oct. 19, 2009
Campaign Date Sept 2009; Nov. / Dec 2009; May –Dec 2010
BCC Tools and materials; TV/Radio jingles/Talk shows; Drama; Community channels
Community mobilization Demand creation; LLIN hang-up campaign
Distribution 2 per HHs
Mechanisms of distribution Stand-alone campaigns
Monitoring and evaluation LQAS (Sept 2009); MIS (2010);
LLIN Follow-up Survey: USAID (2009, Kano) and SuNMap (2009, Anambra)
Case management (ACTs)ACTs required 2009: 37,877,320 doses (30% coverage)
2010: 130,297,982 (100% coverage)
Already distributed: 8.3m
Procurement schedules (ACTs)
Ordered: 2m (GF); 2m (WBBP 1), delivery date: August 2009
Procurement initiated already: 7m (WBBP II)
Procurement to be initiated after R8 is signed : 56m
Procurement to be initiated in 2010: 8m WBBP II; FGN and States 9.5m; DFID/ SuNMap = 2m; USAID 1.2m;
BCC Continuously: Improve Health seeking behaviour and informed demand for commoditiesEarly recognition of signs and symptoms and management by COPRsCommunity sensitizationEmpowerment of CORPs for prompt referral in suspected complicated cases
Mechanisms of distribution HF treatments (Public and Private),
Community and Home Management (PPMVs and RMMs, CBDs, etc),
Drug Efficacy Monitoring Sentinel Sites monitoring sites increased from 6 to 14 in 2008
2009: 3 Sites may commence DET in 2009
2010: National DET implementation, planning and training has commenced
Monitoring and evaluation 2009: Results of NDHS 2008 released, showed 25% and 22% IMR and U5MR reduction respectively
2009: Evaluation of WBBP performance using LQAS in selected States
2009: HF Assessment conducted for WBBP States and 2 non WBBP States
2009: Planning for MIS, Program Performance review commenced
ACTs resources available to achieve the 2010 targets
ACT doses SOURCE COMMENT
when Available Total Need Gap
3,374,509 ACTs3,250,000 ACTs2.400,000 ACTs
FGN/MDGSFHGF R4
Distributed 2009Distributed 2009Distributed 2009
9,024,509 (early 2009)
37.2m for 2009 28,175,491 as @ August 2009
850,000 ACTs9,354,707ACTs600,000 ACTs
GF R4WBUSAID
Expected 2009Expected 2009Expected 2009
10,804,707 (2009)
28,175,491 as @ August 2009
17,370,784 for remaining 2009
18m ACTs53.3m ACTs600,000 ACTs9.5m2.0m
WB GF R8USAIDMDGDFID
Expected 2010Expected 2010Expected 2010Expected 2010Expected 2010
83,462,730 (2010)
101,019,333 17.556,603
TOTAL 103,291,946 (entire 2009 -2010)94,267,437 (expected so far for Sept 2009 -2010)
138,219,333 (entire 2009-2010)129,194,824 (from Sept 2009-2010)
34,927,387
Case management (Parasite based diagnosis -1)
Microscopy Total required: 1000 (2009)
Acquired: 14 (Baseline=14 in Sentinel sites)
Gap: 986 microscopes
Cost is @ USD450 / microscope
Procurement schedule:
-- Nov 09 (175 by WBBP);
-- Procurement commences when R8 grant is signed, 405 in 2009 and 406 in 2010.
RDTs required 2009: 29,135,153 (30% coverage nationwide)
NB: Discounting potential 70% coverage in 2009 in 7 WBBP States)
2010: 30,067,098 (30% nationwide)
NB: Discounting 60% coverage in 7 WB States
Total: 59,202,251
Cost = USD1 / strip
Procurement schedules (RDTs)
2009: Procurement initiated already: 7.1m (WBBP II);
Procurement to be initiated in 2010: 5.03m (GF); 20.12m WBBPII)
Training Policy revised; Tools updated; Tool production is on-goingTrained 14 Sentinel Sites Lab. Scientists; User-friendly training manuals are being producedToT commences in October 2009Support from: GF R8 and WBBP
Case management (Parasite based diagnosis -2)
BCC Continuously: Health care Worker reorientation on RDTs Awareness creation for Health Care Seekers on RDTs
Mechanisms of distribution
Using morbidity data from HFs direct distribution will be to:
HF treatments (Public and Private)
Under GF R8: Two PRs (NMCP and SFH in 3 Northern and 3 Southern States respectively)
WBBP: 4 Northern and 3 Southern States
Drug Efficacy Monitoring / Quality Assurance
In all Sentinel Sites monitoring sites
WHO TDR certified Laboratories will quality assure
Monitoring and evaluation
Supportive supervision
2009: Evaluation of WBBP performance using LQAS in selected States
2009: HF Assessment conducted for WBBP States and 2 non WBBP States
2009: Planning for MIS, Program Performance review commenced
RDT resources available to achieve the 2010 targets
FUNDS AVAILABLE (US $) SOURCE COMMENT
BCC resources available to achieve the 2010 targets
FUNDS AVAILABLE (US $)
SOURCE COMMENT
when Available Total Need Gap
LLINs CampaignsRoutineIRSEnv. MgtCase Mgt (jingles)Printing MaterialsKnow the FactsIPTLLINs CampaignsLLINs CampaignsRoutineIRSEnv. MgtCase Mgt (Jingles)
WBWBWBWBWBWB WB WBWBGF R8WHOAMFmWB (NIFFA)USAID
Already coveredAlready coveredAlready coveredAlready coveredAlready coveredAlready coveredAlready coveredAlready coveredExpected 2010Expected 2010Expec ted 2010Expected 2010Expected 2010Expected 2010
$220,400 $72,782$72, 782$34,220$757,789$72,782$38,114$72,782$1m$4.8m$350,000$............$2m$350,000
$1,334,417.66(2009)
$8,500,000
0
0
IRS resources available to achieve the 2010 targets
FUNDS AVAILABLE (US $) SOURCE COMMENT
Indoor Residual Spraying:Total HHs targeted 8% coverage of Total HHs = 2,540,843
85% of HHs/structures per targeted LGAs;
Pyrethroids required Lamdacyhalothrin CS 10%: 0.030 g/m2Alphacypermethrine WP10%: 0.030 g/m2Bifenthrine 10% WP: 0.050 g/m2Carbamate
Procurement schedules Procurement of IRS logistics: Some in 2008; more in Sept. 2009
Release of funds by WBBP to the IRS Contractors: Dec 2009
Distribution Distribution of IRS logistics to the target districts
Implementation of IRS: Sept 2009; March 2010; Sept 2010.
Training Training of spray personnel – commenced already; March 2010; Sept 2010
(ToTs in collaboration with private sector partners)
Implementation of IRS: Sept 2009; March 2010; Sept 2010
BCC Advocacy and BCC/IEC campaigns: July 2009 – Dec 2010
Spraying Supervision and monitoring including quality assurance: Sept 2009; March 2010; Sept 2010. Data management and report writing: Oct 2009; July 2010Feedback Nov 2009; August 2010; Dec 2010
Monitoring and evaluation (bioassays, insecticide resistance etc)
Conduct insecticide susceptibility studies: Sept 2009; March 2010 (Sentinel sites PIs)
Baseline entomological and epidemiological studies: July 2009;
TA from WHO Reconnaissance and Evaluation, ANVR, etc: (Nov 2009; July 2010; Jan 2011
IPTp resources available to achieve the 2010 targets
FUNDS AVAILABLE (US $) SOURCE COMMENT
Intermittent Preventive Therapy:SP doses required Distributed 5,353,098 doses(as @ July 2009);
Required 2009 = 7,693,928 @ 50% coverage (Gap =2,340,830)
Required in 2010 = 16m @ 100% coverage
Total = 23,081,584m; 18.3m (from Sept 2009-Dec 2010)
Procurement schedules All doses of SPs will be procured by Governments and Partners
WBBP II in & States: August 2009; Dec 2009; 2010
Government (MDG and States) in all FMCs and States: April 2010
DFID / SuNMap in selected States: Dec 2009
Distribution Logistics support through WBBP and States, LGAs
Implementation through ANC clinics; DOT at public and private health facilities; on a continuous basis
Training Training: On-going with GF-R2 Phase II and WBBP; More trgs through in all States with support from GF-R8. It will go on till 2010
BCC Improve ANC attendance to increase IPT uptake; Improve Health seeking behaviour and informed demand for commoditiesEarly recognition of signs and symptoms
Monitoring and evaluation HF Assessment done (May / June 2009)
Community Survey using LQAS (2009)
Program Performance Review (June 2009 - 2010)
MIS Evaluation (Sept 2009 - 2010)
Other core interventions to be delivered over the next 17 months
• HSS issues:– Improving utilization of ANC services– Recruiting and training community health workers– Community systems strengthening
• GF R8 HSS Component
– Strengthen NHMIS• GF R8 MAL and HSS Component
– Expand HR capacity• Recruitment at all levels
• Secondment
• TAs from Partners and Private-Publication Partnership
– Coordination:• ATM task Force, CCM, PRs’ Forum; TWGs, Partners, Bi-Annual
Review and Planning ; State Support Teams; State Partners forum; etc
Summary of rate-limiting factors over the next 17 months
• Gap of 10m LLINs and key operational issues (costs, taxes and tariffs) to achieve SUFI including shortage in operational costs
• Sub-optimal capacity at sub-national levels
• Under utilization of commodities (Nets)
• Surveillance, M&E: delay and under-reporting
Summary of technical assistance needs to end 2010
Need From whom
Capacity building for program managers on CM, LLIN, IRS, MIP, M&E and PM
WHO, UNICEF, WB, AMP, JHIPIEGO,
Financial Management support KPMG, GF,
Partnership / Coordination RBM-HWG, All Partners
Program performance review WHO, CDC,
Malaria Indicator Survey (MIS) WHO, UNICEF, MEASURES, MERG, WB, GF
Drug Efficacy Trial WHO, WAMNAT, WB, GF, Consortium of RBM Experts in Research / Academia, NAFDAC,
Capacity building for program managers on IRS, WHO, IRS Partners e.g.
Capacity building on Pharmaco-vigillance WHO, MSH, CF
Capacity building on PSM MSH, USAID Deliver, WHO,
STATE Region Jan-10 Feb-10 Mar-10 Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10
7Benue NC 1,956,504
15FCT NC 657,956
23Kogi NC 1,520,266
24Kwara NC 1,099,497
26Nasarawa NC 864,019
27Niger NC
32Plateau NC 1,452,658
2Adamawa NE
5Bauchi NE
8Borno NE 1,962,617
16Gombe NE
35Taraba NE 1,061,704
36Yobe NE 1,102,929
18Jigawa NW
19Kaduna NW 2,731,188
20Kano NW
21Katsina NW 2,686,074
22Kebbi NW 1,463,712
34Sokoto NW
37Zamfara NW 1,526,355
1Abia SE 1,295,126
4Anambra SE
11Ebonyi SE 998,126
14Enugu SE 1,510,440
17Imo SE 1,842,435
3Akwa Ibom SS
6Bayelsa SS 786,037
9Cross River SS
10Delta SS 1,918,986
12Edo SS 1,470,764
33Rivers SS
13Ekiti SW
25Lagos SW 4,220,400
28Ogun SW
29Ondo SW 1,595,636
30Osun SW 1,602,999
31Oyo SW 2,643,613
Total 12,681,618 8,843,591 4,555,007 13,889,825
21,525,209 18,444,832